Becca Stanek is an experienced writer and editor who is passionate about exploring the ways we can feel better mentally and physically to get the most out of our lives. She has worked for publications ...
The 3-year disease-free survival rate was 86.4% in the atezolizumab arm and 76.6% in the control arm. Adding atezolizumab to adjuvant treatment with mFOLFOX6 (folinic acid, fluorouracil, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback